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Background: CD4 T cells produce IL-4 that drives Th2 cell differentiation. Early production of IL-4 in naïve T cells leads
to Th2 cell differentiation.
Results: Thp5, a novel peptide, regulates IL-4 production in early activated CD4 T cells.
Conclusion: Early activated CD4 T cells produce Thp5, which plays a critical role in the differentiation of Th2 cells.
Significance: Thp5 acts as an important determinant of Th2 cell differentiation during early T cell activation.
The differentiation of naïve CD4 T cells into T helper 2
(Th2) cells requires production of the cytokine IL-4 in the local
microenvironment. It is evident that naïve/quiescently acti-
vated CD4 T cells produce the IL-4 that drives Th2 cell differ-
entiation. Because early production of IL-4 in naïve T cells leads
to preferential Th2 cell differentiation, this process needs to
be tightly regulated so as to avoid catastrophic and misdirected
Th2 cell differentiation. Here, we show that Thp5, a novel pep-
tide with structural similarity to vasoactive intestinal peptide,
regulates production of early IL-4 in newly activated CD4 T
cells. Induction of IL-4 in CD4 T cells by Thp5 is independent
of the transcription factor STAT6 but dependent on ERK1/2
signaling. Furthermore, cytokines (IL-12 and TGF-) that
promote the differentiation of Th1 or Th17 cells inhibit Thp5
induction, thus suppressing Th2 cell differentiation. We fur-
ther showed that Thp5 enhances Th2 responses and exacer-
bates allergic airway inflammation in mice. Taken together,
our findings reveal that early activated CD4 T cells produce
Thp5, which plays a critical role as a molecular switch in the
differentiation of Th cells, biasing the response toward the
Th2 cell phenotype.
In addition to expressing peptide-boundmajor histocompat-
ibility complex (MHC) and co-stimulatory molecules, profes-
sional antigen-presenting cells produce polarizing cytokines
that drive the differentiation of T helper (Th)8 cells. Antigen-
presenting cell-derived interleukin (IL)-12 directs Th1 differ-
entiation, whereas IL-6 and transforming growth factor
(TGF)- instruct Th17 differentiation (1). In contrast, differen-
tiation of Th2 cells requires IL-4, which is not produced by
professional antigen-presenting cells. It has been suggested that
in some situations the initial IL-4 is produced by third-party
cells, such as natural killer T cells, eosinophils, or basophils (2,
3). However, this hypothesis cannot explain how third-party
cells become activated in response to specific antigens to
induce Th2 cell differentiation, or how Th2 differentiation
occurs in the absence of such cells. Alternatively, the early
source of IL-4 might be the interacting CD4 T cells them-
selves. Indeed, it has been reported that freshly activated naïve
CD4T cells produce IL-4 that can drive Th2 differentiation in
some settings (4–6). As this early IL-4 is the key determinant
for the differentiation of Th2 cells, its production must be
tightly regulated so as to avoid unwanted biased Th2 responses.
Here, we show that T helper cell-induced peptide 5 (Thp5), a
novel peptide with structural similarity to vasoactive intestinal
peptide, regulates production of early IL-4 in newly activated
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CD4 T cells. Induction of IL-4 in CD4 T cells by Thp5 is
independent of the transcription factor signal transducer and
activator of transcription (STAT)6 but dependent on extracel-
lular signal-regulated kinases (ERK)1/2 signaling. Furthermore,
cytokines (IL-12 and IL-6 plus TGF-) that promote the differ-
entiation of Th1 or Th17 cells inhibit Thp5 induction, thus
suppressing Th2 cell differentiation. We further showed that
Thp5 enhances Th2 responses and exacerbates allergic airway
inflammation (AAI) in mice. Taken together, our findings
reveal that early activated CD4 T cells produce Thp5, which
plays a critical role as a molecular switch in the differentiation
of Th cells, biasing the response toward the Th2 cell phenotype.
EXPERIMENTAL PROCEDURES
Animals, Bacterial Strains, Vectors, and Antibodies—
BALB/c, C57BL/6, ERK1/, STAT6/, and OT-II T cell
receptor transgenic mice were purchased from the Jackson
Laboratories. CD1d/ mice have been described (7). -CD3
and -CD28 antibodies were purchased from eBioscience.
Escherichia coli (E. coli) host strain BL21 (DE3) and the plasmid
vector pET23a were purchased from Novagen (Darmstadt,
Germany). The pMD18-T vector was purchased from Takara
(Dalian, China). Yeast extract and peptone for bacterial media
were purchased from Oxoid (Hampshire, UK).
Construction of Recombinant Expression Vector pET23a-
p5—Temperature gradient PCR was performed to obtain the
Thp5 cDNA using a murine cDNA library as the template.
Temperature gradient PCR revealed that 62 °C was the optimal
temperature for renaturation. The amplified fragment was
cloned into pMD18-T vector and confirmed by sequencing.
cDNA for the murine Thp5 gene was then released from
pMD18-T-Thp5 and inserted in-frame into the prokaryotic
expression vector pET23a to obtain the expression vector
pET23a-Thp5. The obtained recombinant clones were identi-
fied byNdeI andXhoI digestion. Both restriction enzymediges-
tion and DNA sequencing confirmed that the constructed
pET23a-Thp5 vector had a correct sequence/structure.
Polyclonal Antibody Production—Male Wistar rats, aged
8–10 weeks, were injected intraperitoneally at 14-day intervals
with 50 g of immunogen (Thp5) dissolved in 200 l of PBS
buffer and then emulsified with 200 l of Complete Freund’s
Adjuvant for the first immunization and with Incomplete
Freund’s Adjuvant for subsequent immunizations. Two
booster intravenous injections were applied at 7-day intervals.
Antisera from animals were collected after each booster injec-
tion to monitor the immune response (antibody titer) during
immunization byWestern blotting. 14 days after the last immu-
nization, blood samples were collected, and the obtained anti-
serum was stored at20 °C.
Solution Structure Analysis—An NMR sample was prepared
in 50 mM sodium phosphate buffer containing 150 mM NaCl,
pH 6.8. All NMR experiments were carried out at 298 K on
Bruker Avance III spectrometers equipped with cryogenic tri-
ple-resonance probes, operating at field strengths of 500 and
700MHz. 4,4-dimethyl-4-silapentane-1-sulfonic acid was used
for 1H chemical shift referencing.
Sequence-specific backbone and side chain resonance
assignment were obtained using standard two-dimensional
experiments (15N,1H HSQC, 13C,1H HSQC, 1H,1H TOCSY,
FIGURE 1.Thp5, anovel bioactivepeptide expressed in activatedCD4T cells.Microarray analysis revealed that XM_982708.1 gene is highly up-regulated
in early activated CD4 T cells. A, nucleotide and amino acid sequence of Thp5. B, Thp5 mRNA expression in naïve (CD4 CD44lowCD62Lhigh) CD4 T or total
CD4 T cells early after activation by -CD3 and -CD28 antibodies. C, tissue expression of Thp5 by RT-PCR (top) and Western blotting (bottom; as a positive
control we used immunoprecipitated Thp5 from culture supernatant of CD4 T cells). D, solution-state structure of synthetic Thp5 peptide by NMR spectros-
copy. Left figure shows the ensembleof 40 conformers of Thp5 after Cyana- simulated annealing calculation. Backbonebonds are shown inblue, and side chain
bonds are shown in red. Right figure shows the secondary structure elements on the mean structure of Thp5. Brown segment shows helical region, and gray
segment shows the loops and bends.
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1H,1H NOESY, NOESY mixing time, 100 ms). The sequence-
specific assignments have been deposited in the BioMagRes-
Bank data base, accession number 17584. All spectra were pro-
cessed with Topspin 2.1 (Bruker AG). All data were analyzed
using Cara (8) Distance restraint for structure calculation was
derived from the two-dimensional 1H,1HNOESY spectrum (9).
Structure was calculated with the program Cyana using 200
randomized starting structures (10). The 20 conformers with
the lowest target function values were selected to represent the
NMR structure. The final energy minimization was done using
AMBER. Figures were prepared with programMOLMOL (11).
Real Time PCR—RNA was isolated from whole splenocytes
and CD4 T cells using a kit (Qiagen). 100 ng of total RNAwas
used to synthesize cDNA using oligo(dT)16 primers and
Omniscript RT kit (Qiagen). Thp5, IL-4, and GAPDH primers
(ThP5 forward, 5-TCTACCCCATTGACCATTTC-3 and
ThP5 reverse, 5-TCATCCAAATTCTGGAGGTG-3; IL-4
forward, 5-AGATCACGGCATTTTGAACG-3 and IL-4
reverse, 5-TTTGGCACATCCATCTCCG-3; GAPDH for-
ward, 5-CGTCCCGTAGACAAAATGGT-3 and GAPDH
reverse, 5-TTGATGGCAACAATCTCCAC-3) were used to
quantitate mRNA transcripts using Bio-Rad CFX 100 with uni-
versal cycling conditions: 95 °C for 10 min and 40 cycles (dena-
turation at 95 °C for 15 s, annealing/extension at 62 °C for 1
min).
Isolation of Naïve CD4 T Cells—Spleens and lymph nodes
were macerated using frosted glass slides to isolate T cells and
whole splenocytes. CD4 T cells were enriched by passing
through a nylon wool column. Cells were further isolated by pos-
itive selection using monoclonal antibodies to CD4 coupled with
magnetic beads (MACS Miltenyi Biotec, Auburn, CA) using a
MACSpreparation column. For sortingnaïveCD4Tcells, nylon
wool-enriched cells were stained with anti-CD4, anti-CD44, and
anti-CD62L antibodies. CD4 CD44lowCD62Lhigh naïve T cells
were sorted by using FACS Aria (BD Biosciences).
T Cell Activation and Cytokine Detection—Purified CD4 T
cells and whole splenocytes from different strains of mice were
activated by plate-bound anti-CD3 antibodies (1 g/ml) with
either plate-bound anti-CD28 (2 g/ml) antibodies or soluble
anti-CD28 antibodies, respectively (eBiosocience). Cytokine
levels in culture supernatants were determined by multiplexed
bead array immunoassay using Luminex Technology (Bio-Plex;
Bio-Rad Laboratories).
CD4 T Cell Proliferation—CD4 T cells were cultured in
24-well plates coated with anti-CD3 (1 g/ml) and anti-CD28
(2 g/ml) antibodies. Cells were cultured in the presence of
various concentrations of Thp5 for 48 h and then pulsed with
tritiated thymidine ([3H]TdR, 1.0 Ci/well; Amersham Biosci-
ences) beforemeasuring incorporation of [3H]TdR bymeans of
a cell harvester and liquid scintillation counter (Wallac Trilux,
PerkinElmer Life Sciences) 16 h later.
Induction of AAI—6–8-week-old male ERK1/ and wild-
type (C57BL/6) mice were sensitized by intraperitoneal injec-
tions of Thp5 (100 g) or ovalbumin (100 g) along with alum
(1 mg) in 0.2 ml of PBS on days 0 and 7. On days 15–18, mice
were challenged daily intranasally with Thp5 (0.5 mg/ml in 50
ml of PBS) or ovalbumin alone.Micewere killed after 1 day, and
bronchoalveolar lavage (BAL) fluid was collected by intratra-
cheal infusion of 2ml of PBS, as described (12). Cells in the BAL
fluid were analyzed on slides after hematoxylin & eosin
staining.
FIGURE 2. Thp5 induces T cell proliferation and cytokine production. A, FACS analysis showing that Thp5 binds with CD4 T cells. B, IL-4mRNA expression
in CD4 T cells at early time points after activation with Thp5. C, IL-4 production by sorted naïve (CD4 CD44lowCD62Lhigh) CD4 T cells activated with Thp5.
D, proliferation of naïve (CD4 CD44lowCD62Lhigh) CD4 T cells in response to increasing concentrations of Thp5. E, proliferation of naïve CD4 T cells in
response to Thp5 (1 g/ml). F, IL-4, IFN-, and IL-17 production by purified CD4 T cells activated with increasing concentrations of Thp5.
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FACS Analysis—Spleen cells (1  106) were taken from
C57BL/6 mice and stained with Alexa Fluor-conjugated
(Alexa-Fluor 647 protein labeling kit A20173; Invitrogen) Thp5
along with Alexa Fluor 647-conjugated BSA as a control. Cells
were acquired with a BD FACS CantoTM II (BD Biosciences)
and analyzed by FlowJo (Tree star) software.
Statistical Analysis—Data were analyzed in Excel 2007 and
subjected to Student’s t test for statistical significance. Statisti-
cal significance was considered when p 0.05.
RESULTS ANDDISCUSSION
We investigated the molecular changes in CD4 T cells dur-
ing their early activation by microarray analysis. We repeatedly
found expression of a small protein/peptide (accession number
XM-982708.1; Fig. 1A and supplemental Fig. S1A) designated
Thp5, that is dramatically up-regulated in CD4 T cells early
after activation (Fig. 1B). We further tested whether Thp5 is
produced by newly activated, naïve CD4 T cells. We sorted
CD4CD44lowCD62Lhigh naïveT cells and activated these cells
with plate-bound anti-CD3 and anti-CD28 antibodies. We
found that naïve CD4 T cells also produced Thp5 and with
kinetics similar that of the total pool of CD4 T cells (Fig. 1B).
Next, we tested the distribution of expression in different
organs and immune cell types and found that Thp5 is expressed
predominantly in lymphoid organs with the highest expression
in CD4 T cells (Fig. 1C). We cloned and expressed Thp5 as a
polyhistidine-tagged (His tag) fusion peptide in E. coli (supple-
mental Fig. S1B) and used the purified fusion peptide to gener-
ate Thp5-specific, polyclonal antisera (supplemental Fig. S1C).
To determine whether Thp5 is expressed alone or as part of a
complex, we immunoprecipitated culture supernatants from
anti-CD3 and anti-CD28 antibody-activated spleen cells with
anti-Thp5 sera, which did not reveal any interacting proteins
(supplemental Fig. S1D), suggesting that it is not a part of any
protein complex. Amino acid sequence analysis followed by
sequence homology analysis was unable to identify significant
homology with any known cytokines, chemokines, or bioactive
peptides. However, solution structural analysis by NMR spec-
troscopy revealed a helical structure with a bend in the middle,
resembling vasoactive intestinal peptide (Fig. 1D) (13). The
coordinates of all 40 conformers have been deposited with the
Protein Data Bank. The corresponding Protein Data Bank code
is 2LMA. The sequence-specific NMR resonance assignments
have been deposited in the BioMagResBank data base, acces-
sion number 17584.
Vasoactive intestinal peptide assists in the differentiation of
Th2 cells and Treg cells (14–16). Therefore, we tested the
kinetics of Thp5 expression in CD4T cells upon activation by
plate-bound anti-CD3 and anti-CD28 antibodies. Interestingly,
we found that Thp5 is expressed very early after activation,
within 3–6 h (Fig. 1B). Next, we investigated the expression of
FIGURE 3. Thp5 induces Th2 cell differentiation and AAI. A, Th2 cell differentiation by Thp5 determined by intracellular IL-4 production in the presence of
anti-IL12. B, inflammatory cells in the BAL fluid of mice with ovalbumin (OVA)-induced AAI. C, histological analysis of lungs of wild-type littermates (C57BL/6)
induced for AAI and treated with or without Thp5. D, Th2 cytokines in the BAL fluid of mice induced for AAI and treated with Thp5. Results shown here are
representative of three independent experiments.
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the putative receptor of Thp5 on splenocytes. We conjugated
recombinant Thp5 or ovalbumin with green fluorescent pro-
tein (GFP) and stained splenocytes.We found that Thp5 bound
with CD4 T cells and most other cell types in the spleen (Fig.
2A). To determine the functional effects of Thp5 on CD4 T
cells, we cultured purified CD4 T cells with plate-bound anti-
CD3 and anti-CD28 antibodies in the presence or absence of
Thp5. We found an early burst of IL-4 production by CD4 T
cells (Fig. 2B). To confirm the role of Thp5 in the production of
this early burst of IL-4, we neutralized Thp5with Thp5-specific
rat antiserum (supplemental Fig. S2A) and observed a strong
suppression of early IL-4 production (Fig. 2B). We also tested
whether Thp5 assists in the differentiation of CD4Tcells with
an IL-4-producing phenotype. For this purpose, we activated
CD4 CD44lowCD62Lhigh naïve T cells with plate-bound anti-
CD3 and anti-CD28 antibodies in the presence or absence of
Thp5 or anti-Thp5 antibodies. Cells were stained for intracel-
lular IL-4.We found that inhibition ofThp5 dramatically inhib-
its, whereas supplementation of Thp5 significantly up-regu-
lates, the differentiation of IL-4-producing cells (Fig. 2C). To
confirm further that activated/memory T cells are not the
source of IL-4, we performed similar experiments with spleno-
cytes from OT-II T cell receptor transgenic mice, which pro-
duced IL-4 to a similar extent as splenocytes from wild-type
animals (supplemental Fig. S2C). Because CD1d-restricted nat-
ural killer T cells produce copious amounts of IL-4 early after
activation (17), we tested Thp5-induced IL-4 production in
splenocytes from CD1d-deficient (CD1d/) animals. We
found no difference in IL-4 production compared with wild-
type splenocytes, suggesting that natural killer T cells are not
the major source of Thp5-induced IL-4 (supplemental Fig.
S2B). Next, we evaluated whether Thp5 assists in the prolifera-
tion and activation of CD4 T cells. For this purpose, we acti-
vated purified CD4 T cells with a suboptimal dose of plate-
bound anti-CD3 and anti-CD28 antibodies, in the presence of
increasing concentrations of Thp5, andmeasured proliferation
and cytokine production 3 days later.We found that Thp5 aug-
ments proliferation of CD4 T cells in a dose-dependent man-
ner (Fig. 2D). We also observed that similar to the total pool of
CD4 T cells, proliferation of naïve CD4 T cells was aug-
mented by the presence of Thp5 (Fig. 2E). To assess whether
Thp5 induces a biased differentiation of Th cells, we deter-
mined cytokine production in the culture supernatants. We
found that Thp5 dramatically induces IL-4 production in both
spleen cells and purified CD4 T cells, but has only modest
effects on the production of IFN- and IL-17, suggesting that
this peptide assists in the differentiation of IL-4-producing Th
cells (Fig. 2F). As expected, addition of anti-Thp5 sera abro-
gated IL-4 production in both spleen cells and purified CD4T
cells.
To assess whether Thp5 alone, in the absence of exogenous
IL-4, can induce Th2 differentiation, we activated CD4T cells
with plate-bound anti-CD3 and anti-CD28 antibodies in the
presence of Thp5 and anti-IFN- for 4 days and determined
intracellular levels of IL-4. Interestingly, we found that Thp5
alone was sufficient to drive Th2 cell differentiation (Fig. 3A).
To evaluate the role of Thp5 in vivo, we induced AAI in mice
treated with or without Thp5. Animals that received Thp5
exhibited significantly higher lung inflammation as evidenced
by the increased infiltration of inflammatory cells in the bron-
choalveolar lavage fluid (Fig. 3B) and by histological analysis of
lung tissue (Fig. 3C). Consistent with these findings, we
observed a dramatic increase in Th2 cytokines in the BAL fluid
(Fig. 3D). Collectively, these observations suggested that Thp5
FIGURE 4. Thp5 induces IL-4 production in a STAT6-independent and ERK-dependentmanner. A, early burst of IL-4 mRNA expression in the presence of
Thp5 inSTAT6/andERK/ knock-outmice.B, inflammatory cells in theBAL fluidsofwild-type littermates (C57BL/6) andERK/mice induced forAAI.C, IL-4
concentration in the BAL fluid of wild-type littermates (C57BL/6) and ERK/mice induced for AAI.D, histology of lungs of wild-type littermates (C57BL/6) and
ERK/mice induced for AAI. E, Thp5 mRNA expression analysis in CD4 T cells in the presence of Th1-differentiating cytokine (IL-12) or Th17-differentiating
cytokines (IL-6TGF-) at different time points.
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rapidly induces IL-4 in naïve CD4 T cells, which assists in the
differentiation of Th2 cells.
Differentiation of Th2 cells is dependent on the availability of
IL-4 in the microenvironment, with a critical role for the tran-
scription factor STAT6 (18). Therefore, we examined whether
early IL-4 production induced by Thp5 is dependent on
STAT6. For this purpose, we activated spleen cells derived from
STAT6/ mice in the presence of Thp5. We found that the
early burst of IL-4 is independent of STAT6 (Fig. 4A), which is
consistent with prior studies showing that STAT6 induction in
CD4 T cells requires at least 48 h of activation. Previous
reports have suggested that ERK1/2 is involved in the differen-
tiation of Th2 cells (6, 19, 20) and that ERK1/2 are induced very
early after activation. Thus, we tested whether Thp5-induced
IL-4 is dependent on ERK1/2. We activated spleen cells from
ERK1/ mice in the presence of Thp5, which revealed that
Thp5 was unable to induce IL-4 in splenic CD4 T cells from
ERK1/mice (Fig. 4A). This finding was further strengthened
by our observation that ERK1/ mice have dramatically
reduced susceptibility to AAI than their wild-type littermates,
as demonstrated by the reduced infiltration of inflammatory
cells (Fig. 4B) and lower levels of Th2 cytokines (Fig. 4C) in the
BAL fluid. Histological analysis also revealed dramatically
reduced inflammation in the lungs of ERK1/mice (Fig. 4D).
Our findings suggest that the early production of IL-4 by acti-
vated CD4 T cells is regulated by the presence of Thp5 in the
microenvironment. However, because Thp5 is also produced by
early activated T cells, its expression must also be regulated to
permit differentiation of other Th cell subsets, namely Th1 and
Th17 cells. Thus, we tested the regulation of Thp5 expression in
the presence of theTh1- andTh17-differentiating cytokines IL-12
and IL-6plusTGF-, respectively. Interestingly,we found that the
presence of either of these cytokines in the culture medium dra-
matically inhibited Thp5 expression (Fig. 4E).
Taken together, our findings indicate that Thp5 is a novel bio-
active peptide that is producedby early activatedCD4Tcells in a
STAT6-independent but ERK1/2-dependent manner. Thp5
induces IL-4 production in CD4 T cells in an autocrine fashion,
which plays an important role in the differentiation of Th2 cells.
Furthermore, the availability of Th1- and/or Th17-differentiating
cytokines in the local microenvironment dramatically inhibits
Thp5production.Thus,Thp5acts as an importantdeterminantof
Th2 cell differentiation during early T cell activation.
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